Marie C. Béné

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 922 citations · Full text

Hematological Malignancy, Radiation Oncology, Medicine +9

Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

Torsten Haferlach, Alexander Kohlmann, Lothar Wieczorek et al. · Journal of Clinical Oncology · 2010 · 668 citations · Full text

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

Soluble Triggering Receptor Expressed on Myeloid Cells and the Diagnosis of Pneumonia

Sébastien Gibot, Aurélie Cravoisy, Bruno Lévy et al. · New England Journal of Medicine · 2004 · 633 citations · Full text

Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study

Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux et al. · Journal of Clinical Oncology · 2009 · 556 citations · Full text